We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AAF:LSEAirtel Africa Plc Analysis

Data as of 2026-08-01 - not real-time

£333.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Airtel Africa trades around £333, just below its 20‑day SMA of £338.5 and marginally above the 200‑day SMA of £336.2, indicating a neutral technical stance. The MACD histogram is positive (0.39) and the signal line has turned bullish, while the RSI sits at 45.8, suggesting room for upside without immediate overbought pressure. Volume is increasing and price sits comfortably above the identified support at £316.8, yet volatility remains high at ~40% over the past 30 days, and beta is low (0.30), reflecting limited market‑wide price sensitivity.
Fundamentally, the company delivers strong growth—revenues rose 30.5% YoY with gross margins near 67% and operating margins above 34%. Return on equity is robust at 26%, and cash flow generation comfortably exceeds dividend commitments (payout 36.6%, yield 1.6%). Although leverage is high (debt‑to‑equity ~184x), the DCF model places fair value near £1,121, implying a modest upside of roughly 13%. The recent announcement to list Airtel Money in London adds a catalyst that could unlock additional value.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram with increasing volume
  • Price near support level offering downside protection
  • High short‑term volatility (~40% 30‑day) limiting upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth (30% YoY) and high operating margins
  • Undervaluation indicated by DCF fair value and 13% upside potential
  • Upcoming London listing of Airtel Money providing a catalyst

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained high ROE and cash‑flow generation supporting dividend
  • Long‑term expansion of mobile‑money and data services across Africa
  • Diversified revenue mix offsetting high leverage over time

Key Metrics & Analysis

Financial Health

Revenue Growth30.50%
Profit Margin10.37%
P/E Ratio23.8
ROE26.41%
ROA10.71%
Debt/Equity183.62
P/B Ratio5.0
Op. Cash Flow£3.4B
Free Cash Flow£1.3B
Industry P/E15.7

Technical Analysis

TrendNeutral
RSI45.8
Support£316.80
Resistance£357.60
MA 20£338.48
MA 50£342.89
MA 200£336.25
MACDBullish
VolumeIncreasing
Fear & Greed Index92.88

Valuation

Fair Value£1,121.11
Target Price£377.41
Upside/Downside13.34%
GradeUndervalued
TypeGrowth
Dividend Yield1.60%

Risk Assessment

Beta0.30
Volatility39.90%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.